Roche Submits sNDA For New Chemotherapy Regimen In Metastatic Colorectal Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Application is for Xelox (Xeloda plus oxaliplatin) with or without Genentech’s Avastin.